Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective studyCarmine Zoccali, Rainer H. Böger, Stefanie M. Bode‐Böger et al.|The Lancet|2001Cited by 1.1k
Adiponectin, Metabolic Risk Factors, and Cardiovascular Events among Patients with End-Stage Renal DiseaseCarmine Zoccali, Yūji Matsuzawa, Francesca Mallamaci et al.|Journal of the American Society of Nephrology|2002Cited by 761
Plasma Norepinephrine Predicts Survival and Incident Cardiovascular Events in Patients With End-Stage Renal DiseaseCarmine Zoccali, Lorenzo Malatino, Sebastiano Cutrupi et al.|Circulation|2002Cited by 522
Vitamin D levels and patient outcome in chronic kidney diseasePietro Ravani, Carmine Zoccali, Fabio Malberti et al.|Kidney International|2008Cited by 436
Atherosclerotic Renal Artery StenosisCarmine Zoccali, Pietro Finocchiaro, Francesca Mallamaci|Journal of the American Society of Nephrology|2002Cited by 429